Andrea Hermina Gyorfi
Overview
Explore the profile of Andrea Hermina Gyorfi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bergmann C, Hallenberger L, Fakhouri S, Merlevede B, Brandt A, Dees C, et al.
Ann Rheum Dis
. 2021 Apr;
80(8):1048-1056.
PMID: 33903093
Objective: X-linked inhibitor of apoptosis protein (XIAP) is a multifunctional protein with important functions in apoptosis, cellular differentiation and cytoskeletal organisation and is emerging as potential target for the treatment...
2.
Gyorfi A, Schett G, Distler J
Ann Rheum Dis
. 2020 Oct;
81(12):e242.
PMID: 33004332
No abstract available.
3.
Gyorfi A, Kopp M, May M, Vetter M, Uder M, Kremer A, et al.
Ann Rheum Dis
. 2020 Jul;
80(6):e87.
PMID: 32606044
No abstract available.
4.
Zhang Y, Shen L, Zhu H, Dreissigacker K, Distler D, Zhou X, et al.
Ann Rheum Dis
. 2020 Jun;
79(9):1227-1233.
PMID: 32482644
Objectives: Coactivators are a heterogeneous family of transcriptional regulators that are essential for modulation of transcriptional outcomes and fine-tune numerous cellular processes. The aim of the present study was to...
5.
Gyorfi A, Matei A, Distler J
Matrix Biol
. 2018 Jan;
68-69:8-27.
PMID: 29355590
Transforming growth factor-β (TGF-β) is widely recognized as a core pathway of fibrosis. Inhibition of TGF-β signaling may thus offer potential for antifibrotic therapies. Long-term inhibition of TGF-β signaling at...